{
  "ptid_time": "131_S_1389_2007-03-16",
  "img_path": "/data/qiuhui/data/adni/images/131_S_1389/2007-03-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,660 mm³, 49.7% above the reference mean. With a Z-score of 1.19 (88.3th percentile), this represents mild enlargement; hippocampal volume measures 5,873 mm³, 22.3% below the reference mean. With a Z-score of -2.18 (1.5th percentile), this represents significant atrophy; whole brain volume measures 958,591 mm³, 11.2% below the reference mean. With a Z-score of -1.45 (7.3th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,307 mm³, 43.7% below the reference mean. With a Z-score of -2.97 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,548 mm³, 28.1% below the reference mean. With a Z-score of -2.39 (0.8th percentile), this represents significant atrophy; middle temporal gyrus volume measures 11,656 mm³, 45.4% below the reference mean. With a Z-score of -4.08 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 76.1 years. Gender is Male. Education: 18 years. Handedness: Left. Race: White. Medical history: Cardiovascular; Malignancy; Major Surgical Procedures. MMSE: 29.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, and middle temporal gyrus), particularly with profound atrophy in the middle temporal gyrus (Z-score -4.08). However, the MMSE score of 29 is within the normal range, suggesting preserved cognitive function despite structural changes. The presence of one APOE4 allele increases Alzheimer's risk but does not confirm disease.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (High structural evidence of neurodegeneration, but cognitive performance remains intact, making early-stage MCI more likely than dementia. Follow-up cognitive testing or biomarker confirmation would strengthen confidence.)",
  "timestamp": "2025-07-26T15:13:00.211334"
}